U.S. markets open in 44 minutes

Perrigo Company plc (PRGO)

NYSE - NYSE Delayed Price. Currency in USD
29.62-1.29 (-4.17%)
At close: 04:00PM EST
29.48 -0.14 (-0.47%)
Pre-Market: 08:45AM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close30.91
Bid11.85 x 800
Ask0.00 x 800
Day's Range29.34 - 31.07
52 Week Range26.81 - 40.28
Avg. Volume1,543,690
Market Cap4.014B
Beta (5Y Monthly)0.90
PE Ratio (TTM)370.25
EPS (TTM)0.08
Earnings DateFeb 26, 2024 - Mar 01, 2024
Forward Dividend & Yield1.09 (3.69%)
Ex-Dividend DateNov 30, 2023
1y Target Est44.67
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
-22% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for PRGO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Perrigo Company plc
    Analyst Report: Perrigo Company PLCPerrigo, founded in 1887, is a leading manufacturer of generic over-the-counter healthcare products and supplier of infant formulas for the store-brand market. Perrigo's private-label consumer products encompass a variety of cold/allergy, gastrointestinal, first aid, motion sickness, vitamin, smoking cessation, and other remedies. The company has a market cap of approximately $4 billion after divesting its RX pharmaceutical business in 2021. Headquartered in Dublin, Ireland, Perrigo has approximately 10,000 employees.
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more